HeartSciences (HSCSW) Change in Account Payables (2021 - 2026)
HeartSciences (HSCSW) reported Change in Account Payables of $93337.0 for Q1 2026, down 27.21% on a YoY basis from $128228.0 in Q1 2025, and up 173.19% quarter-over-quarter from $34165.0 in Q4 2025.
HeartSciences (HSCSW) Change in Account Payables (2021 - 2026) Analysis & Trends
HeartSciences has reported Change in Account Payables for 6 years, with the latest figure at $93337.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 27.21% year-over-year to $93337.0; the trailing twelve-month figure through Jan 2026 stood at $5651.0 (up 156.51% YoY), and the FY2025 full-year result was -$129522.0, up 29.29% from the prior year.
- Change in Account Payables for Q1 2026 stood at $93337.0, up from $34165.0 in the prior quarter.
- The five-year high for Change in Account Payables was $633457.0 in Q4 2023, with the low at -$673221.0 in Q1 2024.
- Historically, Change in Account Payables has averaged $5037.3 across 5 years, with a median of -$28194.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Account Payables soared 970.47% — and 2024, when it sank 374.31%.
- HeartSciences' Change in Account Payables stood at $339522.0 in 2022, then jumped by 86.57% to $633457.0 in 2023, then tumbled by 118.89% to -$119658.0 in 2024, then jumped by 128.55% to $34165.0 in 2025, then surged by 173.19% to $93337.0 in 2026.
- The last three Change in Account Payables figures came in at $93337.0 (Q1 2026), $34165.0 (Q4 2025), and -$35436.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | HeartSciences | - | - | - | 93,337.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 93,337.00 |
| Jan 31, 2026 | 93,337.00 |
| Oct 31, 2025 | 34,165.00 |
| Oct 31, 2025 | 34,165.00 |
| Jul 31, 2025 | -35,436.00 |
| Jul 31, 2025 | -35,436.00 |
| Apr 30, 2025 | -86,415.00 |
| Apr 30, 2025 | -86,415.00 |
| Jan 31, 2025 | 128,228.00 |
| Jan 31, 2025 | 128,228.00 |
| Oct 31, 2024 | -119,658.00 |
| Oct 31, 2024 | -119,658.00 |
| Jul 31, 2024 | -51,677.00 |
| Jul 31, 2024 | -51,677.00 |
| Apr 30, 2024 | 33,107.00 |
| Apr 30, 2024 | 33,107.00 |
| Jan 31, 2024 | -673,221.00 |
| Jan 31, 2024 | -673,221.00 |
| Oct 31, 2023 | 633,457.00 |
| Oct 31, 2023 | 633,457.00 |